Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal

NEXT STORY
GeoVax Provides Update on HIV Clinical Trials Program
PREV STORY
electroCore Receives FDA Clearance for gammaCore™ (nVNS) for Adjunctive Use for the Preventive Treatment of Cluster Headache in Adults
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharmaceuticals At Digestive Disease Week Conference, Nears Selecting Drug Formulation Company to Prepare Oral Brilacidin for Targeted Delivery in Ulcerative Colitis

author_avatar
NASDAQ Market News

Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar

author_avatar
NASDAQ Market News

AIT Therapeutics Announces Positive Preliminary Data for the Primary Endpoint of Safety in Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients

No Serious Adverse Events Related to Treatment with Nitric Oxide Reported Compelling Preliminary Data ...

author_avatar
NASDAQ Market News